Kalpana Gupta Shekhawat: Low Ferritin and Its Impact on Dopamine Signaling
Kalpana Gupta Shekhawat, Chairperson at the Functional and Metabolic Medicine Academy, Gurugram, India, shared a post on LinkedIn:
“Low Ferritin and Its Impact on Dopamine Signaling
Nighttime restlessness in the legs is often simplified-magnesium, stretching, or stress are commonly blamed.
While these approaches can offer relief in some cases, they don’t fully explain a pattern many individuals describe: an urge to move the legs that appears predominantly at night, just as the body is trying to settle into rest.
When symptoms follow this timing, it is worth looking beyond the muscles and considering the brain.
Deep within the midbrain lies the substantia nigra, a small but critical structure involved in dopamine production and movement regulation.
Dopamine plays a key role not only in coordination during the day but also in reducing unnecessary movement at night, allowing the body to transition into deeper stages of sleep.
When dopamine signaling is not optimal, the ability to remain still can be affected.
One important factor influencing this pathway is iron.
Iron is required for the enzyme that converts tyrosine into L-DOPA, the first step in dopamine production.
Ferritin, which reflects the body’s stored iron, helps indicate whether sufficient iron is available for this process.
When ferritin levels drop too low, dopamine production and signaling may be impacted.
What often creates confusion is that many individuals with these symptoms are told their lab results are ‘normal’.
Routine testing typically focuses on hemoglobin to assess anemia, but hemoglobin primarily reflects oxygen transport in the blood. It does not necessarily reflect how much iron is available for the brain.
Iron metabolism is also tightly regulated. Factors such as inflammation, nutrient cofactors like copper and vitamin A, and even circadian rhythms can influence how iron is stored and utilized.
In some cases, the issue is not simply iron deficiency, but how effectively iron is being mobilized and made available to tissues.
Seen together, these symptoms often lie at the intersection of ferritin levels, dopamine signaling, and sleep physiology.
Recognizing this connection allows for a more complete and nuanced understanding of what the body may be signaling”

Stay updated with Hemostasis Today.
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC
-
Nov 18, 2026, 13:32Maria Elisa Mancuso: Next-Generation Protein Therapies in Hemophilia
-
Nov 18, 2026, 13:25Maia Meier: Advocating for Women and Girls with Bleeding Disorders
-
Nov 18, 2026, 13:19Sjoerd Fabian Koopman: Exploring Tissue Distribution of Extended Half-Life Factor IX Concentrates
-
Nov 18, 2026, 13:16Ifeanyichukwu Ifechidere: Choosing Between Clot-Based and Chromogenic Coagulation Assays